申请人:The Brigham and Women's Hospital, Inc.
公开号:US09045484B2
公开(公告)日:2015-06-02
The present invention provides pyridinyl-substituted pyrazolyl pyrimidine small molecule inhibitors of bone morphogenetic protein (BMP) signaling having the structure of formula (I),
wherein variables A, B, E, F, X, Y, Z, Ar, L1, R4 and R15 are as defined in the specification. The compounds of the invention are useful in modulating cell growth, differentiation, proliferation, and apoptosis, and thus are useful for treating diseases or conditions associated with BMP signaling, including inflammation, cardiovascular disease, hematological disease, cancer, and bone disorders, as well as for modulating cellular differentiation and/or proliferation.
本发明提供了一种具有式(I)结构的吡啶基取代的吡唑基嘧啶小分子抑制剂,该抑制剂对骨形态发生蛋白(BMP)信号通路具有抑制作用,其中变量A、B、E、F、X、Y、Z、Ar、L1、R4和R15如规范中所定义。本发明的化合物可用于调节细胞生长、分化、增殖和凋亡,并因此可用于治疗与BMP信号通路相关的疾病或状况,包括炎症、心血管疾病、血液疾病、癌症和骨疾病,以及调节细胞分化和/或增殖。